FrançaisParis, France and Camberley, UK – 30 June 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s Annual Report and Accounts (“Annual Report”) for the year ended 31 December 2019 has been published and uploaded to the Company’s website. The Annual Report will be posted to
Visit PageCategory: Uncategorized
Launch of three innovative products to support COVID-19 testing
Paris, France and Camberley, UK – 18 June 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the launch of three new products to support laboratories testing for COVID-19. These are Exsig™ Direct and Exsig™ Mag, two RNA extraction kits for use prior to running a polymerase chain reaction
Visit PageEarly settlement of term loan and convertible bond facility removes long term debt
Paris, France and Camberley, UK – 3 June 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces it will settle all outstanding debt obligations with Harbert European Growth Capital (“HEGC”) and Vatel Capital SAS (“Vatel”). http://novacyt.com/wp-content/uploads/2020/06/Novacyt-Early-settlement-of-term-loan-03-06-20-ENGLISH.pdf
Visit Page